Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

(2010) Wellington Sun et al.   Human vaccines & immunotherapeutics

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

(2009) Stephen J. Thomas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens

(2009) Wayne D. Crill et al.   PLoS One

Neutralizing antibody response variation against dengue 3 strains

(2008) Mayling Alvarez et al.   JOURNAL OF MEDICAL VIROLOGY

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

(2008) C.-Y. Lai et al.   JOURNAL OF VIROLOGY

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

(2008) John T. Roehrig et al.   VIRAL IMMUNOLOGY